Paul W. Hoelscher - Jan 4, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, CFO
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 4, 2022
Transactions value $
-$5,159,825
Form type
4
Date filed
1/6/2022, 07:58 PM
Previous filing
Dec 30, 2021
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +66.8K +6370.07% 67.9K Jan 5, 2022 Direct F1
transaction HZNP Ordinary Shares Award $0 +47.4K +69.8% $0.00 115K Jan 5, 2022 Direct F2
transaction HZNP Ordinary Shares Tax liability -$5.16M -50.7K -43.96% $101.84 64.6K Jan 5, 2022 Direct
holding HZNP Ordinary Shares 179K Jan 4, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSU) Award $0 +9.52K $0.00 9.52K Jan 4, 2022 Ordinary Shares 9.52K Direct F1, F3
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -18K -100% $0.00* 0 Jan 5, 2022 Ordinary Shares 18K Direct F1, F4
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -14.5K -50% $0.00 14.5K Jan 5, 2022 Ordinary Shares 14.5K Direct F1, F5
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11.1K -50% $0.00 11.1K Jan 5, 2022 Ordinary Shares 11.1K Direct F1, F6
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11.6K -66.7% $0.00 5.8K Jan 5, 2022 Ordinary Shares 11.6K Direct F1, F7
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11.6K -33.33% $0.00 23.3K Jan 5, 2022 Ordinary Shares 11.6K Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2022, the PSUs vested as to the number of shares reported above.
F3 The RSU's vest 1/3rd annually on each anniversary of January 5, 2022.
F4 The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
F5 The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
F6 50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023.
F7 Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.
F8 The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.